1. Nonleadlikeness and leadlikeness in biochemical screening
Gilbert M. Rishton
Drug Discovery Today
Volume 8, Issue 2, 15 January 2003, Pages 86-96
Код: Выделить всё
http://dx.doi.org/10.1016/S1359644602025722 Olivier Roche,† Petra Schneider,† Jochen Zuegge,† Wolfgang Guba,† Manfred Kansy,† Alexander Alanine,† Konrad Bleicher,† Franck Danel,† Eva-Maria Gutknecht,† Mark Rogers-Evans,† Werner Neidhart,† Henri Stalder,† Michael Dillon,‡ Eric Sjögren,‡ Nader Fotouhi,§ Paul Gillespie,§ Robert Goodnow,§ William Harris, Phil Jones, Mikio Taniguchi, Shinji Tsujii, Wolfgang von der Saal,# Gerd Zimmermann,# and Gisbert Schneider*†
J. Med. Chem., 2002, 45 (1), pp 137–142
Код: Выделить всё
http://dx.doi.org/10.1021/jm010934dSusan L. McGovern,‡ Emilia Caselli,‡§ Nikolaus Grigorieff, and Brian K. Shoichet*‡
J. Med. Chem., 2002, 45 (8), pp 1712–1722
Код: Выделить всё
http://dx.doi.org/10.1021/jm010533y